Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

35results about How to "Less treatment" patented technology

Combinations of checkpoint inhibitors and therapeutics to treat cancer

PendingUS20150202291A1Reduces effective amountIncrease subject 's tolerancePeptide/protein ingredientsMammal material medical ingredientsWilms' tumorCancer research
A combination treatment regimen including one or more cycles and / or doses of a checkpoint inhibitor and a therapeutic, either sequentially, in either order, or substantially simultaneously, can be more effective in treating cancer in some subjects and / or can initiate, enable, increase, enhance or prolong the activity and / or number of immune cells, the efficacy of anti-tumor immune responses or a medically beneficial response by a tumor.
Owner:COGNATE BIOSERVICES +3

Yoga ball game controller system and method

ActiveUS8313378B1Encourage physical activityMore funStiltsVideo gamesCar racingBall game
A yoga ball controller communicates motion signals to a game console and a video game executing on the game console to progress play of a game in response to the motion signals. An individual positions himself on the yoga ball and begins to move his body. The controller detects the motion of the individual and communicates signals to the console. The game console recognizes the motion and advances the game play. Motion may be detected using various devices such as a stress ball, a motion sensing mat, and a controller attached to the yoga ball using a harness. The video game may be a well-known, entertaining video game such as one involving car racing, combat, exploration, or puzzle solving. By using a subject other than exercise, game play may be seen as more fun by participants thereby encouraging physical activity.
Owner:HUMANA INC

Aramid cord treatment

A composition and method for treating an aramid cord include a bisphenol-A-based- and / or a bisphenol-F-based-liquid epoxy resin, a reactive diluent, and a curing agent. The composition and method also may include an elastomer-modified epoxy-functional adduct and / or an elastomer-modified epoxy-resin adduct.
Owner:CONTITECH USA INC

Improved solder production process

A process for the production of a crude solder composition includes the provision of a first solder refining slag that includes tin and / or lead. The process furtherincludes the steps of partially reducing the first solder refining slag, thereby forming a crude solder metal composition and a second solder refining slag, followed by separating the second solder refining slag from the crude solder metal composition,and partially reducing the second solder refining slag, thereby forming a second lead-tin based metal composition and a second spent slag followed by separating the second spent slag from the second lead-tin based metal compositionA copper containing fresh feed is added to step (ii), preferably before reducing the second solder refining slag.
Owner:METALLO BELGIUM

Method and device for the separate three-dimensional representation of arteries and veins in an examination object and device

There is described a method for a separate three-dimensional representation of arteries and / or veins of a vascular system in an examination object by means of a tomography x-ray device with the following steps: Implementation of a mask pass of the x-ray device with N projections at N angular positions about the examination object without contrast agent; Implementation of a first filler pass of the x-ray device about the examination object with M projections at M of the N angular positions after injection of a contrast agent, where M<N; Implementation of a second filler pass of the x-ray device about the examination object with N-M projections at N-M of the N angular positions directly following the first filler pass; reconstruction of a composite three-dimensional volume data record from an intermediate data record, said intermediate data record being determined from the data records resulting from the mask pass, the first filler pass and the second filler pass by subtraction and combination; Calculation of a reprojection data record for arteries by reprojection of the angular positions of the first filler pass from the composite three-dimensional volume data record and / or calculation of a reprojection data record for veins by reprojection of the angular positions of the second filler pass from the composite three-dimensional volume data record; calculation of a three-dimensional volume data record for arteries and / or a three-dimensional volume data record for veins by weighting the composite three-dimensional volume data record taking into account the respective measured and the respective calculated projection images.
Owner:SIEMENS HEALTHCARE GMBH

Formaldehyde-contaminated sludge treatment agent and preparation method thereof

The invention discloses a formaldehyde-contaminated sludge treatment agent and a preparation method thereof. The formaldehyde-contaminated sludge treatment agent is prepared from the following raw materials in parts by weight: 15-30 parts of aluminum oxide, 8-14 parts of dibutyl maleate, 4-8 parts of mollugin, 5-10 parts of sodium alkyl benzene sulfonate, 10-15 parts of bamboo vinegar powder, 3-5 parts of capryloyl salicylic acid, 4-11 parts of phosphorous gypsum, 5-12 parts of betel nut powder, 4-8 parts of disodium ethylenediamine tetraacetate, 1-3 parts of tea tree oil, 2-8 parts of cocamidopropyl betaine, 0.1-1 part of an emulsifying agent, 2-4 parts of shell powder, 2-5 parts of cattle bone powder, 0.5-1 part of tea polyphenol, 3-7 parts of toona sinensis leaf powder, 1-4 parts of zeolite powder and 1-3 parts of nano silver. The formaldehyde-contaminated sludge treatment agent provided by the invention has a remarkable treatment effect, is less in consumption during treatment and good in treatment effect, and has the formaldehyde fixation rate of more than 94%.
Owner:ZHENGZHOU UNIV

Composition and method for treatment and prophylaxis of intestinal infection and inflammation

The present invention relates to a composition for use in the treatment and / or prevention of a gastrointestinal condition, comprising at least one Lactobacillus strain, wherein the Lactobacillus strain is chosen from the group consisting of one L. salivarius strain, three L. plantarum strains and one L. brevis strain, wherein the L. salivarius strain is L. salivarius CW30 (LMG P-28887), wherein the L. plantarum strains are L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P-28884), and L. plantarum KS1 1 (LMG P-28885), and wherein the L. brevis strain is L. brevis SH1 1 1 (LMG P-28888). The present invention also relates to an enema comprising a composition according to the present invention. The present invention also relates to an isolated strain chosen from the group L. salivarius CW30 (LMG P-28887), L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P-28884), L. plantarum KS11 (LMG P-28885) and L. brevis SH111 (LMG P-28888). The present invention also relates to an isolated strain of L. salivarius CW30 (LMG P-28887) for use in the treatment and / or prevention of an infection by Clostridium difficile NAP / 027.
Owner:IMMUNEBIOTECH MEDICAL SWEDEN AB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products